본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

목차보기

Title page

Contents

Abbreviations and glossary 5

Executive summary 6

1. Background 6

1.1. Country-specific background 7

1.2. Rationale for active IPD surveillance at the EU/EEA level and in EU Member States 7

1.3. Objectives 7

1.4. Methods 8

1.4.1. Population under surveillance 8

1.4.2. Type of surveillance system 8

1.4.3. Selection of surveillance units 8

1.4.4. Outcomes 8

1.4.5. Data 10

1.4.6. Surveillance responsibilities, reporting and information flow 12

1.4.7. Monitoring and evaluation (depends on type of system) 12

1.4.8. Feedback and supervision 13

1.5. Ethical considerations 13

1.6. Studies on vaccination impact and vaccine effectiveness 13

Selected bibliography 19

Publications 19

Presentations and posters 19

References 22

Tables

Table 1. S. pneumoniae serotypes included in different vaccines 7

Table 2. List of variables, coding, definitions and data sources 13

Table 3. Risk conditions for pneumococcal diseases and corresponding ICD-9 and 10-codes 18